Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Naomi Iwata
Observed names:
Iwata, N,
Iwata, Naomi,
N. Iwata,
NAOMI IWATA,
Naomi IWATA
Institution:
Aichi Children's Health and Medical Center
Observed institutions:
Tokai University,
Shinshu University,
Sapporo Medical University,
Hokkaido University,
Kyoto University,
Ehime University,
Aichi Children's Health and Medical Center,
Nagoya University,
Yokohama City University
show all 9
ORCID:
0000-0001-6149-1358
Observed ORCID:
0000-0001-6149-1358
OpenAlex ID:
A5101500988
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
2008
·
Shumpei Yokota
, Tomoyuki Imagawa
, et al.
·
The Lancet
·
785
Therapeutic efficacy of humanized recombinant anti–interleukin‐6 receptor antibody in children with systemic‐onset juvenile idiopathic arthritis
2005
·
Shumpei Yokota
, Takako Miyamae
, et al.
·
Arthritis & Rheumatism
·
363
Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis
2014
·
N. Kobayashi
, S. Takezaki
, et al.
·
Rheumatology
·
151
Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes
2013
·
Kenji Nakagawa
, Eva Gonzalez-Roca
, et al.
·
Annals of the Rheumatic Diseases
·
126
PDF
Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
2011
·
Tomoyuki Imagawa
, Shumpei Yokota
, et al.
·
Modern Rheumatology
·
85
Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation
2020
·
Tomoko Matsuda
, Naotomo Kambe
, et al.
·
Annals of the Rheumatic Diseases
·
84
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
2012
·
Tomoyuki Imagawa
, Syuji Takei
, et al.
·
Clinical Rheumatology
·
74
PDF
Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan
2014
·
Shumpei Yokota
, Tomoyuki Imagawa
, et al.
·
The Journal of Rheumatology
·
72
PDF
Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update
2020
·
Ichiro Kobayashi
, Shinji Akioka
, et al.
·
Modern Rheumatology
·
64
PDF
Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018
2018
·
Nami Okamoto
, Shumpei Yokota
, et al.
·
Modern Rheumatology
·
54
Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan
2012
·
Shumpei Yokota
, Tomoyuki Imagawa
, et al.
·
Annals of the Rheumatic Diseases
·
54
Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
2020
·
Masaki Shimizu
, Mao Mizuta
, et al.
·
Pediatric Rheumatology
·
50
PDF
Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis
2015
·
Yasuko Kamiya
, Jun-ichi Kawada
, et al.
·
Clinical Rheumatology
·
42
Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry
2020
·
Katsuhiro Arai
, Reiko Kunisaki
, et al.
·
Intestinal Research
·
41
PDF
Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ)
2019
·
Junko Yasumura
, Masato Yashiro
, et al.
·
Pediatric Rheumatology
·
41
PDF
Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis
2020
·
Mao Mizuta
, Masaki Shimizu
, et al.
·
Rheumatology
·
40
Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease: A Postmarketing Surveillance in Japan (SAKURA Study)
2019
·
Masaru Miura
, Tohru Kobayashi
, et al.
·
The Pediatric Infectious Disease Journal
·
30
Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan
2018
·
Naomi Iwata
, Haruna Nakaseko
, et al.
·
Modern Rheumatology
·
30
Assessment of type I interferon signatures in undifferentiated inflammatory diseases: A Japanese multicenter experience
2022
·
Takayuki Miyamoto
, Yoshitaka Honda
, et al.
·
Frontiers in Immunology
·
29
Clinical practice guidance for Sjögren’s syndrome in pediatric patients (2018) – summarized and updated
2020
·
Minako Tomiita
, Ichiro Kobayashi
, et al.
·
Modern Rheumatology
·
28
Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis
2021
·
Chiara De Mutiis
, Scott E Wenderfer
, et al.
·
Rheumatology
·
26
Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis
2015
·
Norimoto Kobayashi
, Ichiro Kobayashi
, et al.
·
The Journal of Rheumatology
·
24
PDF
International cohort of 382 children with lupus nephritis – presentation, treatment and outcome at 24 months
2023
·
Chiara De Mutiis
, Scott E. Wenderfer
, et al.
·
Pediatric Nephrology
·
22
Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis
2017
·
Masaki Shimizu
, Mao Mizuta
, et al.
·
Arthritis Care & Research
·
22
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients
2020
·
Kenichi Nishimura
, Ryoki Hara
, et al.
·
Modern Rheumatology
·
20
PDF
Show more works
View as search
Works count:
89
Citation count:
2,701
H-index:
22
I10-index:
38
Year
Topic
Type
